Literature DB >> 27807358

Autoimmune disease: CK2 blockade ameliorates EAE.

Sarah Crunkhorn.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2016        PMID： 27807358     DOI： 10.1038/nrd.2016.221

Source DB:  PubMed          Journal:  Nat Rev Drug Discov        ISSN： 1474-1776            Impact factor:   84.694


× No keyword cloud information.
  1 in total

1.  Protein kinase CK2 governs the molecular decision between encephalitogenic TH17 cell and Treg cell development.

Authors:  Alexander Ulges; Esther J Witsch; Gautam Pramanik; Matthias Klein; Katharina Birkner; Ulrike Bühler; Beatrice Wasser; Felix Luessi; Natascha Stergiou; Sarah Dietzen; Till-Julius Brühl; Toszka Bohn; Georg Bündgen; Horst Kunz; Ari Waisman; Hansjörg Schild; Edgar Schmitt; Frauke Zipp; Tobias Bopp
Journal:  Proc Natl Acad Sci U S A       Date:  2016-08-23       Impact factor: 11.205
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.